BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 16363239)

  • 1. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation.
    Hatada T; Wada H; Nobori T; Okabayashi K; Maruyama K; Abe Y; Uemoto S; Yamada S; Maruyama I
    Thromb Haemost; 2005 Nov; 94(5):975-9. PubMed ID: 16363239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.
    Yasuda T; Ueda T; Takeyama Y; Shinzeki M; Sawa H; Nakajima T; Ajiki T; Fujino Y; Suzuki Y; Kuroda Y
    Pancreas; 2006 Nov; 33(4):359-63. PubMed ID: 17079940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
    Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
    Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
    Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
    Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
    Kotajima N; Kanda T; Fukumura Y; Kobayashi I
    J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of plasma high mobility group box-1 in disseminated intravascular coagulation with leukemia.
    Wang M; Mei H; Kou H; Deng J; Wang H; Guo T; Hu Y
    Thromb Res; 2015 Aug; 136(2):422-6. PubMed ID: 26049171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
    Eskici ZM; Açıkgöz Ş; Pişkin N; Mungan G; Can M; Güven B; Köktürk F
    Acta Biochim Pol; 2012; 59(4):561-6. PubMed ID: 23094260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma level of IL-1 beta in disseminated intravascular coagulation.
    Wada H; Tamaki S; Tanigawa M; Takagi M; Mori Y; Deguchi A; Katayama N; Yamamoto T; Deguchi K; Shirakawa S
    Thromb Haemost; 1991 Apr; 65(4):364-8. PubMed ID: 2057918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis.
    Lindström O; Tukiainen E; Kylänpää L; Mentula P; Rouhiainen A; Puolakkainen P; Rauvala H; Repo H
    Pancreas; 2009 Nov; 38(8):e215-20. PubMed ID: 19786934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma interleukin-6 in patients with disseminated intravascular coagulation].
    Minamikawa K; Wada H; Ohiwa M; Kaneko T; Tsukada T; Kageyama S; Kobayashi T; Tomeoku M; Katou M; Minami N
    Rinsho Ketsueki; 1992 Dec; 33(12):1797-801. PubMed ID: 1479690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.
    Ueno T; Ikeda T; Ikeda K; Taniuchi H; Suda S; Yeung MY; Matsuno N
    J Surg Res; 2011 Nov; 171(1):183-90. PubMed ID: 20338589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.
    Stegmayr BG; Banga R; Berggren L; Norda R; Rydvall A; Vikerfors T
    Crit Care Med; 2003 Jun; 31(6):1730-6. PubMed ID: 12794412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.